Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NEPHROPLUSBSE : 544647ISIN CODE : INE428V01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE553.4539.1 (+7.6 %)

PREV CLOSE ( ) 514.35

OPEN PRICE ( ) 523.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11819

TODAY'S LOW / HIGH ( )517.30 556.25

52 WK LOW / HIGH ( )445 619.05

NSE553.9538.7 (+7.51 %)

PREV CLOSE( ) 515.25

OPEN PRICE ( ) 514.00

BID PRICE (QTY) 553.95 (1)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 90946

TODAY'S LOW / HIGH( ) 514.00 557.00

52 WK LOW / HIGH ( )446 616

Chairman	Vikram Vuppala
Managing Director	Vikram Vuppala
Company Secretary	Kishore Kathri
Nominee Director	Vishal Vijay Gupta Gaurav Sharma Sunil Kumar Thakur
Non Executive Independent Director	Om Prakash Manchanda Hemant Sultania Annette Berit Ingrid Kumlien Ajay Bakshi

Incorporation Year : 18-12 2009

Registered Office :

Address : 5th Floor, D Block,Ilabs Centre, Plot 18, Software Units Layout,Survey No. 64, Madhapur,, Shaikpet Hyderabad,
Telangana-500081 .

Phone : 040 4240 8039

Industry : Hospital & Healthcare Services

Listing : BSE,NSE